Synapse - Britta Weigelt

Search Within

Britta Weigelt

Results (63)

A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer

Journal Article

Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
Clinical Cancer Research (2025)

Fulltext@MSK | Save

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

Journal Article

Finch, L.; Andres, S.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Selenica, P.; Jang, D.; O'Cearbhaill, R. E.; more...
International Journal of Gynecological Cancer (2025)

Fulltext@MSK | Save

Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer

Journal Article

Sullivan, M. W.; Graves, S.; Adkoli, A.; Zhou, Q.; Iasonos, A.; Ellenson, L. H.; Chi, D. S.; Aghajanian, C.; Liu, Y. L.; Sonoda, Y.; more...
Cancer (2025)

Fulltext@MSK | Save

Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer

Journal Article

Graves, S.; Sullivan, M. W.; Adkoli, A.; Zhou, Q.; Iasonos, A.; Selenica, P.; Aghajanian, C.; Liu, Y. L.; Tew, W.; Sonoda, Y.; more...
Gynecologic Oncology (2025)

Fulltext@MSK | Save

Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer

Meeting Abstract

Sullivan, M.; Graves, S.; Adkoli, A.; Zhou, Q.; Iasonos, A.; Ellenson, L.; Chi, D.; O'Cearbhaill, R.; Weigelt, B.; Grisham, R.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Lymph node metastases in endometrial cancer: A modern assessment in the era of sentinel lymph node mapping and molecular classification

Meeting Abstract

Praiss, A.; Dagher, C.; Zhou, Q.; Iasonos, A.; Rios-Doria, E.; Abu-Rustum, N.; Weigelt, B.; Ellenson, L.; Leitao, M.; Mueller, J.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity

Journal Article

Brodeur, M. N.; Dopeso, H.; Zhu, Y.; Longhini, A. L. F.; Gazzo, A.; Sun, S.; Koche, R. P.; Qu, R.; Rosenberg, L.; Hamard, P. J.; more...
Science Advances (2024)

Fulltext@MSK | Save

ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype

Journal Article

Brodeur, M. N.; Selenica, P.; Ma, W.; Moufarrij, S.; Dagher, C.; Basili, T.; Abu-Rustum, N. R.; Aghajanian, C.; Zhou, Q.; Iasonos, A.; more...
Molecular Oncology (2024)

Fulltext@MSK | Save

Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping

Journal Article

Praiss, A. M.; Dagher, C.; Zhou, Q.; Iasonos, A.; Rios-Doria, E.; Abu-Rustum, N. R.; Chiang, S.; Momeni-Boroujeni, A.; Weigelt, B.; Ellenson, L. H.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)

Meeting Abstract

Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Carey, L. A.; Melisko, M. E.; Syldor, A.; Friedman, C.; Savoie, J.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save